Reflections about the Clinical Microbiology Laboratory Response to the COVID-19 Pandemic: Testing, Science, and “Making it Work”

This Content is only for members, Please login to view.

Joint Providership Accreditation Statement:
Must Read: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the College of American Pathologists and the New York Pathological Society. The College of American Pathologists is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement:
Must Read: The College of American Pathologists designates this live educational activity for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Disclaimer:
Must Read: The content of this CME activity does not necessarily reflect the view or policies of the College of American Pathologists.

Learning Objectives:

1. Understand the landscape of available SARS-CoV-2 diagnostic tests and their use and interpretation in current clinical practice
2. Recognize obstacles to standing up, scaling up, and sustaining access to diagnostic testing that have faced clinical laboratories during the early part of the COVID-19 pandemic in the U.S.
3. Describe how the science of viral genomic epidemiology can be applied to improve our understanding of the spread of SARS-CoV-2

Organizer(s):

Isabel Fiel, MD – President
Nada Farhat, MD – Vice President
Virginia M. Pierce- Speaker

A resident or fellow trainee qualifies for junior membership.